A-4952-16T1 - IN RE: ACCUTANE LITIGATION (MCL-271, ATLANTIC COUNTY AND STATEWIDE)
A-25-17 In re: Accutane Litigation (079958)
Supreme Court Strengthens Standard for Use of Expert Testimony
Order Admitting To Practice Pro Hac Vice - Marie Woodbury
Court Axes Accutane Suits, Adopts 'Daubert' Standard for Expert Reports | New Jersey Law Journal
NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this Time Regarding Choice-of-Law and the Presumption of Adequacy for FDA-Approved Warnings | McCarter & English, LLP
Order Admitting Ina Chang - Schedule A
Facing thousands of Accutane claims, Roche wins appeal of $18M jury verdict | Fierce Pharma
Untitled
Supreme Court of New Jersey Archives - Government & Law Blog
Roche faces more than 2K Accutane liability cases as appeals panels reverse rulings | Fierce Pharma
NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A
Order Admitting Richard Hansen - Schedule A
NJ Supreme Court Issues Another Landmark Decision in In re Accutane, this Time Regarding Choice-of-Law and the Presumption of Adequacy for FDA-Approved Warnings | McCarter & English, LLP
New Jersey Appellate Panel Reverses Trial Court's Detailed Exclusion of Unreliable Expert Testimony - Life Science Matters
New Jersey Expert Admissibility Standard: “Reconciled” with Daubert
ORDER TO DELETE submitted by Case Management Staff October 30, 2017 | Trellis
In re Accutane Litigation, 234 N.J. 340 (N.J. 2018)
Everything You Need to Know About Microdosing Accutane for Acne
Accutane Lawsuit Status – Injuries & Jury Verdicts
Expert Evidence | New Jersey Civil Justice Institute
The New Jersey Supreme Court Has Adopted the Expert Admissibility FACTORS AND Gatekeeping Function of the Trial Court's Enunciat
Order Granting Summary Judgment on Lack of Proximate Cause Schedule A and Schedule B
Untitled
On the WLF Legal Pulse
